Critical illness induces alternative activation of M2 macrophages in adipose tissue
暂无分享,去创建一个
G. Van den Berghe | L. Langouche | J. Gunst | Catherine Ingels | A. D'hoore | S. Vander Perre | S. Derde | M. Marques | Sarah Derde
[1] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[2] G. Van den Berghe,et al. Alterations in adipose tissue during critical illness: an adaptive and protective response? , 2010, American journal of respiratory and critical care medicine.
[3] J. Ochoa,et al. Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. , 2009, The Journal of trauma.
[4] M. Munder. Arginase: an emerging key player in the mammalian immune system , 2009, British Journal of Pharmacology.
[5] Isao Usui,et al. Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice , 2009, Diabetes.
[6] A. Chawla,et al. Mechanisms of macrophage activation in obesity-induced insulin resistance , 2008, Nature Clinical Practice Endocrinology &Metabolism.
[7] J. A. van der Laak,et al. Peroxisome Proliferator-activated Receptor γ Activation Promotes Infiltration of Alternatively Activated Macrophages into Adipose Tissue* , 2008, Journal of Biological Chemistry.
[8] G. Van den Berghe,et al. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients* , 2008, Critical care medicine.
[9] Frank Brombacher,et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.
[10] A. Saltiel,et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.
[11] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[12] P. Buehler,et al. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. , 2006, Blood.
[13] Ilse Vanhorebeek,et al. Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.
[14] C. Moinard,et al. Polyamines: metabolism and implications in human diseases. , 2005, Clinical nutrition.
[15] F. Brombacher,et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. , 2004, Immunity.
[16] Dieter Mesotten,et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. , 2004, The Journal of clinical endocrinology and metabolism.
[17] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[18] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[19] S. Ridley,et al. Drugs in anaesthesia , 2003, Anaesthesia.
[20] G. Van den Berghe,et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. , 2003, The Journal of clinical endocrinology and metabolism.
[21] A. Aljada,et al. Insulin as an anti-inflammatory and antiatherosclerotic hormone. , 2003, Clinical cornerstone.
[22] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[23] B. Boulanger,et al. Arginase I Expression and Activity in Human Mononuclear Cells After Injury , 2001, Annals of surgery.
[24] S. Moestrup,et al. Identification of the haemoglobin scavenger receptor , 2001, Nature.
[25] J. Lehmann,et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. , 2000, Molecular cell.
[26] G. Strassmann,et al. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. , 1996, Cellular immunology.
[27] B. Spiegelman,et al. 15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.
[28] B. Spiegelman,et al. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. , 1995, Cell.
[29] L. Lind,et al. Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. , 1994, Clinical intensive care : international journal of critical & coronary care medicine.
[30] K. Feingold,et al. Tumor necrosis factor, cytokines, and the hyperlipidemia of infection , 1991, Trends in Endocrinology & Metabolism.